Research Institute

Research projects:
Explore the factors for overcoming cancer metastasis

Japanese

Laboratory of Cancer metastasis

Summary of research:

ROS production in low-metastatic P29 cells and high-metastatic A11 cells carrying a pathogenic mtDNA mutation derived from Lewis lung carcinoma. Green : ROS-producing cells
Suppression of lung metastasis by N-acetylcysteine (NAC)

The aim and object of our study is to develop clinically applicable strategies to predict and inhibit metastasis by analyses of factors that confer metastatic ability to tumor cells.
Recently, we found that ROS (reactive oxygen species)-generating pathogenic mitochondrial DNA (mtDNA) mutations enhance metastatic ability of Lewis lung carcinoma cells and mouse fibrosarcoma cells by increasing the expression of hypoxia-inducible factor-1α (HIF-1α) and antiapoptotic Mcl-1. Furthermore, we found that antioxidants can inhibit metastasis caused by such mtDNA mutations.
We are now trying to reveal the relationship between pathogenic mtDNA mutations and metastasis in human tumor cell lines, and also in clinical samples by carrying out prospective and perspective studies, aiming to apply the outcome of the analyses for clinical use in the future.

Keywords:

Metastasis, Mitochondria, Tumor micro-environment, Reactive oxygen species, Hypoxia

Recent main publications:

  • Ishikawa K et al. Science 2008:661-664
  • Ishikawa K et al. FEBS Lett. 2008:3525-3530
  • Ito S et al. Int. J Oncol. 2007:261-268
  • Ito A et al. Biochem Biophys Res Commun. 2006:306-311
  • Koshikawa N et al. Oncogene 2006:917-928

Text the above. The future navigation

  • About CCCRI
  • CCCRI organization
  • Research projects
  • Cooperative Graduate School of Medicine, Chiba University
  • Social activities
  • Research Institute Home
  • Go Japanese

Chiba Cancer Center(Japanese) > Research Institute > Research projects > Explore the factors for overcoming cancer metastasis

copyright CHIBA CANCER CENTER